Opportunity Information: Apply for RFA CA 10 012

  • The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Minority Based Community Clinical Oncology Program Groups (U10)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.393 Cancer Cause and Prevention Research 93.394 Cancer Detection and Diagnosis Research 93.395 Cancer Treatment Research 93.396 Cancer Biology Research 93.397 Cancer Centers Support Grants 93.398 Cancer Research Manpower 93.399 Cancer Control.
  • This funding opportunity was created on Jul 16, 2010 and posted on Jul 16, 2010.
  • Applicants must submit their applications by Sep 16, 2010. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • The funding agency has allocated a total of $2,000,000.00 to eligible and selected applicants.
  • The number of recipients for this funding is limited to 5 candidate(s).
  • Eligible applicants include: For profit organizations other than small businesses Others (see text field entitled Additional Information on Eligibility for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Private institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments).
  • Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
Apply for RFA CA 10 012

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The Minority Based Community Clinical Oncology Program Groups (U10) grant opportunity (Funding Opportunity Number RFA-CA-10-012) is a National Institutes of Health, National Cancer Institute (NCI) funding announcement designed to expand access to NCI-sponsored cancer clinical trials in communities that serve large minority populations. At its core, the program is meant to bring research opportunities and cutting-edge cancer care options closer to where minority patients already receive care, by enabling practicing community oncologists and their organizations to participate directly in national clinical trials focused on cancer prevention, cancer control, and cancer treatment. By supporting these community-based physician networks as a national resource, NCI aims to strengthen the research capacity of providers caring for minority populations and to ensure that trial participation more accurately reflects the diversity of the U.S. population.

A central goal of the Minority Based CCOP model is to increase minority patient enrollment (accrual) into NCI-approved clinical trials. This matters because clinical trial participation has historically been lower among minority and underserved groups for many reasons, including limited trial availability in local settings, logistical barriers, and lack of established trial infrastructure in community practices. Through this program, NCI connects community oncologists and their patients to a broader clinical trials system that includes cancer centers, major university centers, and established community programs. That linkage is intended to speed the transfer of proven research findings into real-world practice in minority communities, so new prevention approaches, symptom-management strategies, and treatment advances reach patients sooner and become part of routine community care.

This opportunity sits within the larger Community Clinical Oncology Program (CCOP) Network, which began in 1983 to promote state-of-the-art cancer clinical trials with strong participation from community oncologists and the populations they serve. The CCOP Network is described as having three main components, each with its own funding announcement: Minority Based CCOPs (the focus of this FOA), standard CCOP Groups (also called CCOPs), and CCOP Research Bases. In practical terms, the Minority Based CCOPs are the community-facing organizations and physician networks that recruit and enroll patients into trials. The CCOP Research Bases are the entities that design and run those trials, handle data management and analysis, and publish results. Research Bases must be located at either an NCI-supported Clinical Cooperative Group or an NCI-designated Cancer Center, ensuring the trials are anchored in established research leadership while enrollment can occur broadly in community settings.

The mission of the CCOP Network, as reflected in this announcement, is threefold. First, it aims to accelerate the development of interventions that prevent cancer, treat cancer, and address cancer-related symptoms by increasing patient enrollment into well-run trials. Second, it seeks to improve the quality of cancer care in community settings by encouraging adoption of evidence-based practices that emerge from those trials. Third, it explicitly prioritizes increasing participation of minority and underserved patients in clinical trials and related research, addressing both equity and the scientific need for results that apply across diverse populations.

Funding is provided through the NIH U10 cooperative agreement mechanism, which generally indicates a collaborative relationship between the awardee and the federal government, with NIH/NCI having substantial programmatic involvement compared with a standard grant. The announcement is categorized as discretionary funding and is listed under broad health and education activity areas, reflecting its dual emphasis on clinical research participation and the spread of best practices into community care. The estimated total funding level is $2,000,000 with an expected five awards, and there is no cost-sharing or matching requirement stated for applicants.

Eligibility is broad and includes many types of institutions and organizations that could plausibly support a community oncology clinical trials network. Eligible applicants include public and private institutions of higher education, nonprofit organizations (including those with and without 501(c)(3) status), for-profit organizations other than small businesses, Native American tribal governments and tribal organizations, U.S. territories or possessions, and a range of mission-focused institutions and community entities. The announcement specifically notes eligibility for Alaska Native and Native Hawaiian Serving Institutions, Historically Black Colleges and Universities (HBCUs), Hispanic Serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, and eligible federal agencies. This wide eligibility aligns with the program purpose of meeting minority communities where they are, using local and culturally connected institutions as potential anchors for participation.

Key administrative details reflect that this was a time-limited opportunity posted July 16, 2010, with an original and final closing date of September 16, 2010, and an archive date of October 17, 2010. The opportunity is associated with multiple CFDA numbers spanning the cancer research continuum, including prevention, detection and diagnosis, treatment, biology, cancer centers support, research manpower, and cancer control, which underscores that the supported clinical trial activity can touch many domains of cancer research rather than being confined to a single disease area or research type. The full announcement was made available through the NIH Grants Guide (link provided in the source), and technical access issues were directed to the NIH Office of Extramural Research (OER) webmaster contact listed in the notice.

Frequently Asked Questions (FAQs)

What is the Minority Based Community Clinical Oncology Program Groups (U10) opportunity?

It is a National Institutes of Health (NIH), National Cancer Institute (NCI) funding announcement to expand access to NCI-sponsored cancer clinical trials in communities that serve large minority populations. It supports community-based physician networks so practicing community oncologists and their organizations can participate directly in national clinical trials focused on cancer prevention, cancer control, and cancer treatment.

What is the main purpose of this program?

The core purpose is to bring research opportunities and cutting-edge cancer care options closer to where minority patients already receive care by enabling community oncology practices and related organizations to enroll patients in NCI-approved clinical trials.

What is a central goal of the Minority Based CCOP model?

A central goal is to increase minority patient enrollment (accrual) into NCI-approved clinical trials so trial participation more accurately reflects the diversity of the U.S. population.

Why does the FOA emphasize minority patient enrollment in clinical trials?

The announcement notes that clinical trial participation has historically been lower among minority and underserved groups, driven by factors such as limited trial availability in local settings, logistical barriers, and lack of established trial infrastructure in community practices. The program is designed to reduce those barriers by connecting community sites to NCI-supported trial systems.

What types of clinical trials are involved?

The supported work is oriented around NCI-approved clinical trials in cancer prevention, cancer control, and cancer treatment. The broader description also highlights trials that develop and test interventions for prevention, treatment, and cancer-related symptom management.

How does this program connect community oncologists to the national research system?

Through this program, NCI links community oncologists and their patients to a broader clinical trials system that includes cancer centers, major university centers, and established community programs. This linkage is intended to strengthen local research capacity while expanding trial access in community settings.

What is the intended benefit for patient care in minority communities?

The announcement frames the benefit as faster transfer of proven research findings into real-world practice, so new prevention approaches, symptom-management strategies, and treatment advances reach patients sooner and become part of routine community care.

How does this opportunity fit within the broader CCOP Network?

This opportunity is part of the larger Community Clinical Oncology Program (CCOP) Network, which began in 1983 to promote state-of-the-art cancer clinical trials with strong participation from community oncologists and the populations they serve.

What are the three main components of the CCOP Network mentioned in the announcement?

The CCOP Network is described as having three components, each with its own funding announcement: Minority Based CCOPs (the focus of this FOA), standard CCOP Groups (also called CCOPs), and CCOP Research Bases.

What role do Minority Based CCOPs play in the CCOP Network?

Minority Based CCOPs are described as community-facing organizations and physician networks that recruit and enroll patients into clinical trials.

What is a CCOP Research Base and what does it do?

CCOP Research Bases are the entities that design and run the clinical trials, handle data management and analysis, and publish results.

Where must CCOP Research Bases be located?

Research Bases must be located at either an NCI-supported Clinical Cooperative Group or an NCI-designated Cancer Center, which anchors trials in established research leadership while allowing enrollment across community settings.

What are the stated mission areas of the CCOP Network in this announcement?

The announcement describes a three-part mission: (1) accelerate development of interventions to prevent, treat, and manage symptoms related to cancer by increasing enrollment into well-run trials, (2) improve the quality of cancer care in community settings by encouraging adoption of evidence-based practices that emerge from trials, and (3) prioritize increasing participation of minority and underserved patients in clinical trials and related research.

What funding mechanism is used for this opportunity?

Funding is provided through the NIH U10 cooperative agreement mechanism, which generally indicates a collaborative relationship between the awardee and the federal government, with NCI having substantial programmatic involvement compared with a standard grant.

Is this considered discretionary funding?

Yes. The announcement is categorized as discretionary funding.

What activity areas are associated with this opportunity?

The opportunity is listed under broad health and education activity areas, reflecting an emphasis on clinical research participation and the spread of evidence-based best practices into community care.

How much funding is available and how many awards are expected?

The estimated total funding level is $2,000,000, with an expected five awards.

Is cost-sharing or matching required?

No cost-sharing or matching requirement is stated for applicants in the information provided.

Who is eligible to apply?

Eligibility is broad and includes public and private institutions of higher education, nonprofit organizations (including those with and without 501(c)(3) status), for-profit organizations other than small businesses, Native American tribal governments and tribal organizations, and U.S. territories or possessions, among others.

Are minority-serving institutions specifically mentioned as eligible?

Yes. The announcement specifically notes eligibility for Alaska Native and Native Hawaiian Serving Institutions, Historically Black Colleges and Universities (HBCUs), Hispanic Serving Institutions, and Tribally Controlled Colleges and Universities (TCCUs).

Are faith-based or community-based organizations eligible?

Yes. Faith-based or community-based organizations are specifically listed as eligible in the announcement.

Are federal agencies eligible to apply?

Yes. The announcement notes that eligible federal agencies may apply.

What is the Funding Opportunity Number for this announcement?

The Funding Opportunity Number is RFA-CA-10-012.

When was this opportunity posted, and what were the closing dates?

It was posted on July 16, 2010. The original and final closing date was September 16, 2010.

Is this a current opportunity?

Based on the dates provided, it was time-limited and is archived. The archive date listed is October 17, 2010.

What CFDA numbers are associated with this opportunity?

The opportunity is associated with multiple CFDA numbers spanning cancer prevention, detection and diagnosis, treatment, biology, cancer centers support, research manpower, and cancer control, indicating the supported clinical trial activity can touch many domains of cancer research.

Where was the full announcement made available?

The full announcement was made available through the NIH Grants Guide (as referenced in the source information).

Who should be contacted for technical access issues related to the announcement?

Technical access issues were directed to the NIH Office of Extramural Research (OER) webmaster contact listed in the notice.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education Health

Next opportunity: Promote and engage in the protection of the Trail of Tears NHT

Previous opportunity: Community Clinical Oncology Program Research Bases (U10)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA CA 10 012

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (RFA CA 10 012) also looked into and applied for these:

Funding Opportunity
Clinical and Translational Science Coordinating Center (U54) Apply for RFA RR 10 007

Funding Number: RFA RR 10 007
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Health Promotion Among Racial and Ethnic Minority Males (R21) Apply for PA 10 237

Funding Number: PA 10 237
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Instrument Development for Biomedical Applications (R21) Apply for RFA RR 10 009

Funding Number: RFA RR 10 009
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $125,000
Nutrition and Alcohol Related Health Outcomes (R01) Apply for PA 10 239

Funding Number: PA 10 239
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Nutrition and Alcohol Related Health Outcomes (R21) Apply for PA 10 241

Funding Number: PA 10 241
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $275,000
NIDA Program Project Grant Applications (P01) Apply for PAR 10 244

Funding Number: PAR 10 244
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Chimpanzee Biomedical Research Program Limited Competition (U42) Apply for RFA RR 10 008

Funding Number: RFA RR 10 008
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Data Coordinating Center (U10) Apply for RFA HL 11 028

Funding Number: RFA HL 11 028
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Core Clinical Centers (U10) Apply for RFA HL 11 013

Funding Number: RFA HL 11 013
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $115,000
Coordinating Center for the Barretts Esophagus Translational Research Network (U01) Apply for RFA CA 10 015

Funding Number: RFA CA 10 015
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Barretts Esophagus Translational Research Network (U54) Apply for RFA CA 10 014

Funding Number: RFA CA 10 014
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Exceptional, Unconventional Research Enabling Knowledge Acceleration (EUREKA) (R01) Apply for RFA GM 11 003

Funding Number: RFA GM 11 003
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Neuroscience Research on Drug Abuse (R01) Apply for PA 10 268

Funding Number: PA 10 268
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Neuroscience Research on Drug Abuse (R21) Apply for PA 10 269

Funding Number: PA 10 269
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Neuroscience Research on Drug Abuse (R03) Apply for PA 10 270

Funding Number: PA 10 270
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $50,000
Early Career Award in Chemistry of Drug Abuse and Addiction (ECHEM) NIDA (R21/R33) Apply for PAS 10 274

Funding Number: PAS 10 274
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $250,000
Pharmacological Development of Treatment Agents and Formulations for Tobacco Dependence (STTR R41 Apply for RFA DA 11 004

Funding Number: RFA DA 11 004
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $300,000
Developing and Improving Institutional Animal Resources (G20) Apply for RFA RR 10 011

Funding Number: RFA RR 10 011
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $500,000
Innovative Emerging Molecular Analysis Technologies (SBIR R43/R44) Apply for RFA CA 10 013

Funding Number: RFA CA 10 013
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Assay Development for High Throughput Screening for Nicotinic Receptor Subunits (R21) Apply for RFA DA 11 007

Funding Number: RFA DA 11 007
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $150,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 10 012", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.